Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1650
0.00 (0.00%)
Aug 10, 2026, 12:13 PM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 10.4 million as of August 10, 2026. Its market cap has increased by 9.11% in one year.
Market Cap
10.40M
Enterprise Value
11.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
ChartMarket Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 10.40M, a decrease of -18.17%. That is a compound annual growth rate of -3.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 10.40M | 32.81% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Devonian Health Group | 21.55M |
| Pharmala Biotech Holdings | 15.29M |
| Hemostemix | 13.85M |
| Rapid Dose Therapeutics | 12.28M |
| PreveCeutical Medical | 12.24M |
| Britannia Life Sciences | 10.55M |
| Glow Lifetech | 9.62M |
| Kane Biotech | 6.15M |